{"id":6421,"date":"2017-11-10T19:02:20","date_gmt":"2017-11-10T19:02:20","guid":{"rendered":"https:\/\/www.olartemoure.com\/web\/?p=6421\/"},"modified":"2018-01-24T15:49:05","modified_gmt":"2018-01-24T15:49:05","slug":"om-weekly-digest-10-11-2017","status":"publish","type":"post","link":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/","title":{"rendered":"OM Weekly Digest (10-11-2017)"},"content":{"rendered":"

<\/a><\/p>\n

..<\/span><\/p>\n

\n
\n

COLOMBIA\u00a0|\u00a0Regulatory, Compliance |\u00a0Colombia is about to implement\u00a0Disclosure Code on Payments\u00a0from the Pharmaceutical Sector to Healthcare Professionals<\/u><\/strong><\/h3>\n<\/div>\n

\"\"<\/a><\/p>\n

On 1 November 2017, the Ministry of Health (MoH) of Colombia\u00a0published the draft of\u00a0a Resolution through which it will implement a\u00a0Disclosure Code on Payments from the pharmaceutical industry<\/a><\/span>\u00a0-like Marketing Authorization titleholders, manufacturers, importers and distributors of medicines and medical devices- to healthcare professionals\u00a0(HCPs) and other actors\u00a0in the health sector (such as doctors, for example).<\/p>\n

The new regulations\u00a0are a result of new transparency and compliance policies adopted by the Colombian Government, and will involve the report of cash value transfers, services, articles in kind and actions from the pharmaceutical industry in favor of\u00a0HCPs\u00a0involving\u00a0the following categories: (i) food expenses, (ii) travel and accommodation related to participation in events, (iii) education, (iv) research, (v) donations, (vi) licenses for use, (vii) participation as speaker\u00a0in academic events; and (viii) financiation for academic events.<\/p>\n

It is likely that the aforementioned regulation will be issued before the end of 2017, considering that the MoH is already working on the platform that will be used to report and\u00a0disclose\u00a0payments (which is also regulated in the Resolution).<\/p>\n

The Ministry\u00a0will receive comments and observations until 20 November 2017<\/a><\/span>.<\/p>\n<\/div>\n

\n

.\u00a0<\/span><\/h3>\n
\n

COLOMBIA\u00a0|\u00a0Regulatory | Colombian Minister of Health warns that there will be price control for 222 new medicines<\/u><\/strong><\/h3>\n

\"\"<\/a><\/p>\n

In an interview with\u00a0El Tiempo<\/em>\u00a0newspaper<\/a><\/span>, the Colombian Minister announced that the price of 222 new medicines will be controlled, which means that the country will have more than 1000 medicines (specifically 1082)\u00a0under said figure.<\/p>\n

This incorporation would take place on November 2017, and will be carried out according to the final text of the Draft Decree with criteria for medicines\u2019 therapeutic value evaluation, which was discussed in the\u00a0OM Weekly Digest\u00a0edition issued on 20 October 2017<\/a><\/span>.<\/p>\n

.<\/p>\n

.<\/span><\/p>\n<\/div>\n

\n
\n
\n

COLOMBIA<\/strong><\/span>\u00a0|\u00a0Intellectual Property<\/u><\/strong>\u00a0|\u00a0Colombia’s entry into the OECD: Committee of Commerce meets at the end of November and could evaluate the country’s shortfalls in Intellectual Property<\/u><\/strong><\/h3>\n

\"\"<\/a><\/p>\n

According\u00a0with\u00a0Portafolio<\/em>\u00a0newspaper<\/a><\/span>, November 2017 will be crucial for Colombia to\u00a0finally be admitted into\u00a0the Organization for Economic Cooperation and Development (OECD), since the meetings of 2 of a total of 23) Committees of that Organization missing to give\u00a0its approval in the fulfillment of good practices of the country in different thematic areas.\u00a0\u00a0Specifically, the Trade Committee would meet on 26 November 2017, which\u00a0within its most important points will review the intellectual property situation in the country and if measures to adopt the recommendations made by the OECD in the area have been taken<\/a><\/span>.<\/p>\n

Additionally, it should be considered that\u00a0United States (one of the countries with the most weight within the OECD) is actually conducting a Report 301 Out-of-Cycle Review about protection provided by Colombia in intellectual property<\/a>, within of which different US companies and trade unions have requested the inclusion of Colombia in the priority\u00a0watch list of countries that do not fulfill their commitments in the area.<\/p>\n

Although the OCR Review has no direct link with the OECD, its comments and results may have an influence on the review carried out by the Trade Committee and on the approval required by Colombia to advance its entry into OECD.<\/p>\n

.<\/span><\/p>\n<\/div>\n

\n
\n

COLOMBIA<\/strong><\/span>\u00a0|\u00a0Regulatory<\/u><\/strong>\u00a0<\/strong><\/span>|\u00a0Uber, Cabify and Airbnb are legal in Colombia: ICTs Minister<\/u><\/strong><\/h3>\n<\/div>\n<\/div>\n<\/div>\n

\"\"<\/a><\/p>\n

On 4 November 2017,\u00a0the Minister of Technologies and Information (MinICT)\u00a0stated that service intermediation platforms\u00a0like Uber, Airbnb and Cabify are legal.\u00a0 According to the Ministry, the digital economy is a public policy promoted by Colombia and intermediation platforms are adjusted to it<\/a><\/span>.\u00a0 The foregoing is guaranteed by the new neutrality principle, consisting in that any platform can operate online unless there is express legal prohibition in the activity subject of intermediation (which actually is limited to child pornography and chance ganes).<\/p>\n

Notwithstanding the foregoing, there is still no consensus within the Colombian government regarding legality of Uber and Cabify (for example, for the Ministry of Transportation such platforms are illegal).<\/p>\n<\/div>\n

\n
\u00a0.<\/span><\/div>\n
\n
\n

COLOMBIA\u00a0|\u00a0Regulatory |\u00a0Colombia: authorizations to use Living Modified Organisms are now issued by INVIMA<\/strong><\/span><\/h3>\n<\/div>\n

\"\"<\/a><\/p>\n

Starting\u00a023 October 2017, and by delegation of the Colombian Ministry of Health,\u00a0the Regulatory and Sanitary Authority of Colombia (INVIMA in Spanish) became the\u00a0Institution in charge of authorizing permits\u00a0related to Living Modified Organisms (LMOs)<\/a><\/span>.<\/p>\n

Specifically, it will authorize any permit regarding transboundary movement, transit, handling and use of LMOs.<\/p>\n

\n

.<\/span><\/p>\n<\/div>\n

\n
\n

EUROPE, WORLD\u00a0| Competence Law, Antitrust |\u00a0For\u00a0anti-competitive practices, the European Union sanctions Google\u00a0with more than 2,700 million dollars<\/strong><\/span><\/h3>\n<\/div>\n

\"\"<\/a><\/p>\n

On June 2017 -and as a result of an investigation initiated in 2014-,\u00a0the European Union (EU) imposed a fine on Google for more than 2.7 billion dollars (equivalent to 3% of the turnover of Alphabet Inc., the business conglomerate to which Google belongs) for alleged<\/a><\/span>\u00a0a<\/a>nti-competitive practices<\/span>, specifically for distorting the results of its search engine and favoring price comparison offered by Google\u00a0over smaller shopping search services.<\/p>\n

The decision was appealed by Google\u00a0before the\u00a0EU General Court on October 30, 2017, on the grounds that it is unfounded “by relying on antitrust theories not proven by the EU Competition Commissioner”.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n

s anounced by the Colombian President.<\/h3>\n","protected":false},"excerpt":{"rendered":"

.. COLOMBIA\u00a0|\u00a0Regulatory, Compliance |\u00a0Colombia is about to implement\u00a0Disclosure Code on Payments\u00a0from the Pharmaceutical Sector to Healthcare Professionals On 1 November 2017, the Ministry of Health (MoH) of Colombia\u00a0published the draft of\u00a0a Resolution through which it will implement a\u00a0Disclosure Code on Payments from the pharmaceutical industry\u00a0-like Marketing Authorization titleholders, manufacturers, importers and distributors of medicines and […]<\/p>\n","protected":false},"author":1,"featured_media":6727,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[59],"tags":[],"class_list":["post-6421","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-newsletter-en"],"yoast_head":"\nOM Weekly Digest (10-11-2017) - OlarteMoure | Intellectual Property<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"OM Weekly Digest (10-11-2017)\" \/>\n<meta property=\"og:description\" content=\".. COLOMBIA\u00a0|\u00a0Regulatory, Compliance |\u00a0Colombia is about to implement\u00a0Disclosure Code on Payments\u00a0from the Pharmaceutical Sector to Healthcare Professionals On 1 November 2017, the Ministry of Health (MoH) of Colombia\u00a0published the draft of\u00a0a Resolution through which it will implement a\u00a0Disclosure Code on Payments from the pharmaceutical industry\u00a0-like Marketing Authorization titleholders, manufacturers, importers and distributors of medicines and […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/\" \/>\n<meta property=\"og:site_name\" content=\"OlarteMoure | Intellectual Property\" \/>\n<meta property=\"article:published_time\" content=\"2017-11-10T19:02:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2018-01-24T15:49:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/olartemoure.com\/wp-content\/uploads\/2017\/05\/Estetoscopio.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"778\" \/>\n\t<meta property=\"og:image:height\" content=\"518\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\"},\"headline\":\"OM Weekly Digest (10-11-2017)\",\"datePublished\":\"2017-11-10T19:02:20+00:00\",\"dateModified\":\"2018-01-24T15:49:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/\"},\"wordCount\":835,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/Estetoscopio.jpg\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/\",\"name\":\"OM Weekly Digest (10-11-2017) - OlarteMoure | Intellectual Property\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/Estetoscopio.jpg\",\"datePublished\":\"2017-11-10T19:02:20+00:00\",\"dateModified\":\"2018-01-24T15:49:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/#primaryimage\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/Estetoscopio.jpg\",\"contentUrl\":\"https:\\\/\\\/olartemoure.com\\\/wp-content\\\/uploads\\\/2017\\\/05\\\/Estetoscopio.jpg\",\"width\":778,\"height\":518},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/om-weekly-digest-10-11-2017\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"OM Weekly Digest (10-11-2017)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#website\",\"url\":\"https:\\\/\\\/olartemoure.com\\\/\",\"name\":\"OlarteMoure | Intellectual Property\",\"description\":\"Firma especializada en Propiedad Intelectual\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/olartemoure.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/olartemoure.com\\\/#\\\/schema\\\/person\\\/d3c1a99aa6e1d8fc8bb6a5c4dee16807\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"url\":\"https:\\\/\\\/olartemoure.com\\\/en\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"OM Weekly Digest (10-11-2017) - OlarteMoure | Intellectual Property","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/","og_locale":"en_US","og_type":"article","og_title":"OM Weekly Digest (10-11-2017)","og_description":".. COLOMBIA\u00a0|\u00a0Regulatory, Compliance |\u00a0Colombia is about to implement\u00a0Disclosure Code on Payments\u00a0from the Pharmaceutical Sector to Healthcare Professionals On 1 November 2017, the Ministry of Health (MoH) of Colombia\u00a0published the draft of\u00a0a Resolution through which it will implement a\u00a0Disclosure Code on Payments from the pharmaceutical industry\u00a0-like Marketing Authorization titleholders, manufacturers, importers and distributors of medicines and […]","og_url":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/","og_site_name":"OlarteMoure | Intellectual Property","article_published_time":"2017-11-10T19:02:20+00:00","article_modified_time":"2018-01-24T15:49:05+00:00","og_image":[{"width":778,"height":518,"url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2017\/05\/Estetoscopio.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/#article","isPartOf":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/"},"author":{"name":"admin","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807"},"headline":"OM Weekly Digest (10-11-2017)","datePublished":"2017-11-10T19:02:20+00:00","dateModified":"2018-01-24T15:49:05+00:00","mainEntityOfPage":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/"},"wordCount":835,"commentCount":0,"image":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2017\/05\/Estetoscopio.jpg","articleSection":["Newsletter"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/","url":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/","name":"OM Weekly Digest (10-11-2017) - OlarteMoure | Intellectual Property","isPartOf":{"@id":"https:\/\/olartemoure.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/#primaryimage"},"image":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/#primaryimage"},"thumbnailUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2017\/05\/Estetoscopio.jpg","datePublished":"2017-11-10T19:02:20+00:00","dateModified":"2018-01-24T15:49:05+00:00","author":{"@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807"},"breadcrumb":{"@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/#primaryimage","url":"https:\/\/olartemoure.com\/wp-content\/uploads\/2017\/05\/Estetoscopio.jpg","contentUrl":"https:\/\/olartemoure.com\/wp-content\/uploads\/2017\/05\/Estetoscopio.jpg","width":778,"height":518},{"@type":"BreadcrumbList","@id":"https:\/\/olartemoure.com\/en\/om-weekly-digest-10-11-2017\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/olartemoure.com\/en\/"},{"@type":"ListItem","position":2,"name":"OM Weekly Digest (10-11-2017)"}]},{"@type":"WebSite","@id":"https:\/\/olartemoure.com\/#website","url":"https:\/\/olartemoure.com\/","name":"OlarteMoure | Intellectual Property","description":"Firma especializada en Propiedad Intelectual","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/olartemoure.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/olartemoure.com\/#\/schema\/person\/d3c1a99aa6e1d8fc8bb6a5c4dee16807","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/dc39656c8e7d8a5a4ca66eb97abd4b095991d687cfd38af1e37bac8f9cb122b7?s=96&d=mm&r=g","caption":"admin"},"url":"https:\/\/olartemoure.com\/en\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/6421","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/comments?post=6421"}],"version-history":[{"count":0,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/posts\/6421\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media\/6727"}],"wp:attachment":[{"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/media?parent=6421"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/categories?post=6421"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/olartemoure.com\/en\/wp-json\/wp\/v2\/tags?post=6421"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}